To explore Hla’s application as a targeted cancer therapeutic, the mechanism linking Hla pore formation, oligomerisation, ADAM10 binding, and the eventual caspase-dependent cell death needs to be elucidated. This evidence concerns the gene ADAM10 and cancer.